Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price fell 1% on Thursday . The stock traded as low as $0.85 and last traded at $0.85. 202,573 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 653,017 shares. The stock had previously closed at $0.86.
Curaleaf Stock Down 1.0%
The company has a market cap of $564.37 million, a price-to-earnings ratio of -2.93 and a beta of 0.83. The stock's 50-day moving average is $0.86 and its 200-day moving average is $1.24. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. On average, analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
